Surgeon General Nominee Faces Criticism Over Psychedelic Therapy Views

Surgeon General Nominee Faces Criticism Over Psychedelic Therapy Views

President Donald Trump’s new pick for surgeon general has sparked controversy with her views on psychedelic therapy, suggesting that people consider using unproven psychedelic drugs as a form of treatment. The nominee, who has never completed her residency training, has been criticized by experts in the medical field for her lack of qualifications and potential to undermine science-based medicine.

Role of the Surgeon General

The surgeon general’s role is to provide Americans with the best scientific information available on how to improve their health and reduce their risk of illness and injury. Past surgeons general have used this position to educate Americans about health problems like AIDS and suicide prevention. Notably, the surgeon general’s warning in 1964 about the dangers of smoking helped change America’s health landscape.

Concerns Over Qualifications

Some experts are questioning whether this nominee is qualified for the job:

  • Psilocybin, a key psychedelic drug, is illegal under federal law and listed as a Schedule 1 drug due to its lack of accepted medical use and high potential for abuse.
  • While Oregon and Colorado have legalized psychedelic therapy, several cities in Oregon have since banned it.

Critics argue that the nominee’s views may undermine science-based medicine by promoting unproven treatments without proper evidence or testing. Dr. David Katz, founding director emeritus at Yale University School of Medicine Center for Prevention Research & Wellness, expressed serious concerns:

"This person has never completed her residency training. That raises serious concerns about whether she would be able to effectively communicate complex scientific issues."

Dr. John Ioannidis, professor at Stanford University, echoed these concerns:

"We need somebody who understands science-based medicine, not just some celebrity or influencer saying things without any basis whatsoever."

Dr. Peter Lurie, executive director of Public Citizen Health Research Group, added:

"I think we’re going back into another era where science isn’t being followed. It seems like we’ve got someone who thinks she knows better than scientists."

Lack of Transparency in the Nomination Process

The nomination process has been criticized for its lack of transparency. Dr. Lurie noted:

"It was done behind closed doors. There wasn’t any public input."

The American Medical Association (AMA) also expressed concern over the nomination process. AMA President Susan R. Bailey, MD, stated:

"We are troubled by reports that President Trump chose his new Surgeon General nominee behind closed doors without consulting AMA leaders or other stakeholders."

Response to Criticism

In response to criticism from various groups, including:

  • Doctors’ organizations
  • Patients’ rights advocates
  • Civil liberties watchdogs
  • Consumer protection agencies
  • Government agencies
  • Regulatory bodies

Many issued statements expressing concern over the nomination, citing a lack of transparency, accountability, and oversight. The ongoing debate highlights the importance of ensuring that the surgeon general’s position is filled by someone who adheres to science-based medicine and prioritizes public health.

FacebooktwitterlinkedinrssyoutubeFacebooktwitterlinkedinrssyoutube
FacebooktwitterredditpinterestlinkedinmailFacebooktwitterredditpinterestlinkedinmail

Leave a Comment

Your email address will not be published. Required fields are marked *